Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Signal Transduction Signaling Pathway G Protein Signaling Small G Proteins Other

Anti-ABL2 antibody [EPR1222(2)] (ab134134)

Price and availability

234 528 ₸

Availability

Order now and get it on Tuesday March 02, 2021

Anti-ABL2 antibody [EPR1222(2)] (ab134134)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [EPR1222(2)] to ABL2
  • Suitable for: WB, Flow Cyt
  • Reacts with: Mouse, Rat, Human

You may also be interested in

Product image
Anti-CSTF2T antibody (ab80275)
Recombinant human B7H4 protein (Fc Chimera Active) (ab216190)
Product image
Mouse Hemopexin ELISA Kit (HPX) (ab157716)
Product image
Human ALDH1A1 ELISA Kit (ab214024)

Overview

  • Product name

    Anti-ABL2 antibody [EPR1222(2)]
    See all ABL2 primary antibodies
  • Description

    Rabbit monoclonal [EPR1222(2)] to ABL2
  • Host species

    Rabbit
  • Specificity

    The immunogen used for this product shares 85% identity with ABL1. Cross-reactivity with this protein has not been confirmed experimentally.

  • Tested Applications & Species

    Application Species
    Flow Cyt
    Human
    WB
    Human
    See all applications and species data
  • Immunogen

    Synthetic peptide within Human ABL2 aa 500-600. The exact sequence is proprietary.

  • Positive control

    • Jurkat cell lysates; HeLa cell lysates; K562 cell lysates; Molt 4 cell lysates; RAW 264.7 cell lysates; PC 12 cell lysates; NIH 3T3 cell lysates
  • General notes

     

     

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Store at -20°C. Stable for 12 months at -20°C.
  • Dissociation constant (KD)

    KD = 2.36 x 10 -11 M
    Learn more about KD
  • Storage buffer

    pH: 7.20
    Preservative: 0.01% Sodium azide
    Constituents: 9% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA, 50% Tissue culture supernatant
  • Concentration information loading...
  • Purity

    Tissue culture supernatant
  • Clonality

    Monoclonal
  • Clone number

    EPR1222(2)
  • Isotype

    IgG
  • Research areas

    • Signal Transduction
    • Protein Phosphorylation
    • Tyrosine Kinases
    • Other
    • Cancer
    • Signal transduction
    • Protein phosphorylation
    • Tyrosine kinases
    • Other
    • Cancer
    • Oncoproteins/suppressors
    • Oncoproteins
    • Transcription factors

Images

  • Western blot - Anti-ABL2 antibody [EPR1222(2)] (ab134134)
    Western blot - Anti-ABL2 antibody [EPR1222(2)] (ab134134)
    All lanes : Anti-ABL2 antibody [EPR1222(2)] (ab134134) at 1/1000 dilution

    Lane 1 : Jurkat cell lysate
    Lane 2 : HeLa cell lysate
    Lane 3 : K562 cell lysate
    Lane 4 : MOLT 4 cell lysate
    Lane 5 : RAW 264.7 cell lysate
    Lane 6 : PC12 cell lysate
    Lane 7 : NIH 3T3 cell lysate

    Lysates/proteins at 10 µg per lane.

    Secondary
    All lanes : HRP labelled goat anti rabbit at 1/2000 dilution

    Predicted band size: 128 kDa

  • Flow Cytometry - Anti-ABL2 antibody [EPR1222(2)] (ab134134)
    Flow Cytometry - Anti-ABL2 antibody [EPR1222(2)] (ab134134)
    Flow cytometric analysis of permeabilized Jurkat cells labelling ABL2 (red) using ab134134 at 1/10 dilution or using a Rabbit IgG negative control (green)
  • OI-RD Scanning - Anti-ABL2 antibody [EPR1222(2)] (ab134134)
    OI-RD Scanning - Anti-ABL2 antibody [EPR1222(2)] (ab134134)
    Equilibrium disassociation constant (KD)
    Learn more about KD

    Click here to learn more about KD
  • Anti-ABL2 antibody [EPR1222(2)] (ab134134)
    Anti-ABL2 antibody [EPR1222(2)] (ab134134)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-ABL2 antibody [EPR1222(2)] (ab134134)

  •  
  • Product image

    Anti-ABL2 antibody - N-terminal (ab198718)

    Applications: IHC-P, WB

  •  
  • Product image

    Anti-ABL2 antibody (ab126256)

    Applications: WB

Clear all

Recently viewed products

  •  
  • Product image

    Anti-Cytokeratin 6 antibody [EPR1602Y] (ab93279)

  •  
  • Product image

    Anti-RCC1 antibody [EPR5859(2)] (ab181155)

  •  
  • Product image

    Anti-TRA2B/SFRS10 antibody [EPR11831] (ab171082)

  •  
  • Product image

    Anti-TMEM161A antibody [EPR14369] (ab180954)

  •  
  • Product image

    Anti-Retinoic Acid Receptor beta antibody (ab53161)

  •  
  • Product image

    Anti-PDP2 antibody (ab233517)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.